top of page

MIT Device Could Free Those With Type 1 Diabetes From Insulin Injections and Pumps

MIT engineers have developed a groundbreaking implantable device for type 1 diabetes treatment that contains its own "on-board oxygen factory." This innovation addresses the challenge of ensuring transplanted pancreatic islet cells receive sufficient oxygen to produce insulin. The device, roughly the size of a US quarter, has shown promising results in diabetic mice, maintaining stable glucose levels for at least a month. While further testing is needed, this technology offers hope for a more manageable and less invasive treatment for type 1 diabetics.

Photo Credit: Dennis Klicker

4 views0 comments


Não foi possível carregar comentários
Parece que houve um problema técnico. Tente reconectar ou atualizar a página.
bottom of page